A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye.

Although this study was not powered to demonstrate statistical significance for this outcome measure, a clear trend favoring CsA–LE over CsA alone is shown in Figure 2 , with an increase in “candidacy” from 35% to 60% for CsA–LE vs 47% to 43% at baseline vs 4 weeks ( Figure 2 ).

also in 19,460 other papers